REPORT ID 441

EMEA (Europe, Middle East and Africa) Kidney Transplant Rejection Therapeutics Market Report 2017

Publish Date
01-Dec-17
Pages
115
Format
Electronic (PDF)

In this report, the EMEA Kidney Transplant Rejection Therapeutics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Kidney Transplant Rejection Therapeutics for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Kidney Transplant Rejection Therapeutics market competition by top manufacturers/players, with Kidney Transplant Rejection Therapeutics sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
    CSL Limited
    Digna Biotech, S.L.
    GlaxoSmithKline Plc
    Grifols, S.A.
    Hansa Medical AB
    Kyowa Hakko Kirin
    Mabtech Limited
    Magnus Life Ltd
    Noorik Biopharmaceuticals AG
    Novartis AG
    Opsona Therapeutics Limited
    OSE Immunotherapeutics
    Pharmicell Co., Ltd.
    Pharming Group N.V.

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Azathioprine
    Cortina
    Cyclophosphamide
    Cyclosporin A
    Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospital
    Clinic
    ASCs
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Kidney Transplant Rejection Therapeutics Market Report 2017
1 Kidney Transplant Rejection Therapeutics Overview
    1.1 Product Overview and Scope of Kidney Transplant Rejection Therapeutics
    1.2 Classification of Kidney Transplant Rejection Therapeutics
        1.2.1 EMEA Kidney Transplant Rejection Therapeutics Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Kidney Transplant Rejection Therapeutics Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Azathioprine
        1.2.4 Cortina
        1.2.5 Cyclophosphamide
        1.2.6 Cyclosporin A
        1.2.7 Other
    1.3 EMEA Kidney Transplant Rejection Therapeutics Market by Application/End Users
        1.3.1 EMEA Kidney Transplant Rejection Therapeutics Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 ASCs
        1.3.5 Others
    1.4 EMEA Kidney Transplant Rejection Therapeutics Market by Region
        1.4.1 EMEA Kidney Transplant Rejection Therapeutics Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Kidney Transplant Rejection Therapeutics (2012-2022)
        1.5.1 EMEA Kidney Transplant Rejection Therapeutics Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Kidney Transplant Rejection Therapeutics Revenue and Growth Rate (2012-2022)

2 EMEA Kidney Transplant Rejection Therapeutics Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Kidney Transplant Rejection Therapeutics Market Competition by Players/Manufacturers
        2.1.1 EMEA Kidney Transplant Rejection Therapeutics Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Kidney Transplant Rejection Therapeutics Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Kidney Transplant Rejection Therapeutics Sale Price by Players (2012-2017)
    2.2 EMEA Kidney Transplant Rejection Therapeutics (Volume and Value) by Type/Product Category
        2.2.1 EMEA Kidney Transplant Rejection Therapeutics Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Kidney Transplant Rejection Therapeutics Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Kidney Transplant Rejection Therapeutics Sale Price by Type (2012-2017)
    2.3 EMEA Kidney Transplant Rejection Therapeutics (Volume) by Application
    2.4 EMEA Kidney Transplant Rejection Therapeutics (Volume and Value) by Region
        2.4.1 EMEA Kidney Transplant Rejection Therapeutics Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Kidney Transplant Rejection Therapeutics Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Kidney Transplant Rejection Therapeutics Sales Price by Region (2012-2017)

3 Europe Kidney Transplant Rejection Therapeutics (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Kidney Transplant Rejection Therapeutics Sales and Value (2012-2017)
        3.1.1 Europe Kidney Transplant Rejection Therapeutics Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Kidney Transplant Rejection Therapeutics Revenue and Growth Rate (2012-2017)
    3.2 Europe Kidney Transplant Rejection Therapeutics Sales and Market Share by Type
    3.3 Europe Kidney Transplant Rejection Therapeutics Sales and Market Share by Application
    3.4 Europe Kidney Transplant Rejection Therapeutics Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Kidney Transplant Rejection Therapeutics Sales Volume by Countries (2012-2017)
        3.4.2 Europe Kidney Transplant Rejection Therapeutics Revenue by Countries (2012-2017)
        3.4.3 Germany Kidney Transplant Rejection Therapeutics Sales and Growth Rate (2012-2017)
        3.4.4 France Kidney Transplant Rejection Therapeutics Sales and Growth Rate (2012-2017)
        3.4.5 UK Kidney Transplant Rejection Therapeutics Sales and Growth Rate (2012-2017)
        3.4.6 Russia Kidney Transplant Rejection Therapeutics Sales and Growth Rate (2012-2017)
        3.4.7 Italy Kidney Transplant Rejection Therapeutics Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Kidney Transplant Rejection Therapeutics Sales and Growth Rate (2012-2017)

4 Middle East Kidney Transplant Rejection Therapeutics (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Kidney Transplant Rejection Therapeutics Sales and Value (2012-2017)
        4.1.1 Middle East Kidney Transplant Rejection Therapeutics Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Kidney Transplant Rejection Therapeutics Revenue and Growth Rate (2012-2017)
    4.2 Middle East Kidney Transplant Rejection Therapeutics Sales and Market Share by Type
    4.3 Middle East Kidney Transplant Rejection Therapeutics Sales and Market Share by Application
    4.4 Middle East Kidney Transplant Rejection Therapeutics Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Kidney Transplant Rejection Therapeutics Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Kidney Transplant Rejection Therapeutics Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Kidney Transplant Rejection Therapeutics Sales and Growth Rate (2012-2017)
        4.4.4 Israel Kidney Transplant Rejection Therapeutics Sales and Growth Rate (2012-2017)
        4.4.5 UAE Kidney Transplant Rejection Therapeutics Sales and Growth Rate (2012-2017)
        4.4.6 Iran Kidney Transplant Rejection Therapeutics Sales and Growth Rate (2012-2017)

5 Africa Kidney Transplant Rejection Therapeutics (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Kidney Transplant Rejection Therapeutics Sales and Value (2012-2017)
        5.1.1 Africa Kidney Transplant Rejection Therapeutics Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Kidney Transplant Rejection Therapeutics Revenue and Growth Rate (2012-2017)
    5.2 Africa Kidney Transplant Rejection Therapeutics Sales and Market Share by Type
    5.3 Africa Kidney Transplant Rejection Therapeutics Sales and Market Share by Application
    5.4 Africa Kidney Transplant Rejection Therapeutics Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Kidney Transplant Rejection Therapeutics Sales Volume by Countries (2012-2017)
        5.4.2 Africa Kidney Transplant Rejection Therapeutics Revenue by Countries (2012-2017)
        5.4.3 South Africa Kidney Transplant Rejection Therapeutics Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Kidney Transplant Rejection Therapeutics Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Kidney Transplant Rejection Therapeutics Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Kidney Transplant Rejection Therapeutics Sales and Growth Rate (2012-2017)

6 EMEA Kidney Transplant Rejection Therapeutics Manufacturers/Players Profiles and Sales Data
    6.1 CSL Limited
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Kidney Transplant Rejection Therapeutics Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 CSL Limited Kidney Transplant Rejection Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Digna Biotech, S.L.
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Kidney Transplant Rejection Therapeutics Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Digna Biotech, S.L. Kidney Transplant Rejection Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 GlaxoSmithKline Plc
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Kidney Transplant Rejection Therapeutics Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 GlaxoSmithKline Plc Kidney Transplant Rejection Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Grifols, S.A.
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Kidney Transplant Rejection Therapeutics Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Grifols, S.A. Kidney Transplant Rejection Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Hansa Medical AB
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Kidney Transplant Rejection Therapeutics Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Hansa Medical AB Kidney Transplant Rejection Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Kyowa Hakko Kirin
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Kidney Transplant Rejection Therapeutics Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Kyowa Hakko Kirin Kidney Transplant Rejection Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Mabtech Limited
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Kidney Transplant Rejection Therapeutics Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Mabtech Limited Kidney Transplant Rejection Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Magnus Life Ltd
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Kidney Transplant Rejection Therapeutics Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Magnus Life Ltd Kidney Transplant Rejection Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Noorik Biopharmaceuticals AG
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Kidney Transplant Rejection Therapeutics Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Noorik Biopharmaceuticals AG Kidney Transplant Rejection Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Novartis AG
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Kidney Transplant Rejection Therapeutics Product Type, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Novartis AG Kidney Transplant Rejection Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 Opsona Therapeutics Limited
    6.12 OSE Immunotherapeutics
    6.13 Pharmicell Co., Ltd.
    6.14 Pharming Group N.V.

7 Kidney Transplant Rejection Therapeutics Manufacturing Cost Analysis
    7.1 Kidney Transplant Rejection Therapeutics Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Kidney Transplant Rejection Therapeutics

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Kidney Transplant Rejection Therapeutics Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Kidney Transplant Rejection Therapeutics Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Kidney Transplant Rejection Therapeutics Market Forecast (2017-2022)
    11.1 EMEA Kidney Transplant Rejection Therapeutics Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Kidney Transplant Rejection Therapeutics Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Kidney Transplant Rejection Therapeutics Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Kidney Transplant Rejection Therapeutics Price and Trend Forecast (2017-2022)
    11.2 EMEA Kidney Transplant Rejection Therapeutics Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Kidney Transplant Rejection Therapeutics Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Kidney Transplant Rejection Therapeutics Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Kidney Transplant Rejection Therapeutics Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Kidney Transplant Rejection Therapeutics Sales Forecast by Type (2017-2022)
    11.7 EMEA Kidney Transplant Rejection Therapeutics Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer